210 related articles for article (PubMed ID: 35909972)
21. Prognostic factors and treatment comparison in small cell neuroendocrine cervical carcinoma.
Yin ZM; Yu AJ; Wu MJ; Zhu JQ; Zhang X; Chen JH; Yuan SH; Yu H
Eur J Gynaecol Oncol; 2014; 35(3):259-63. PubMed ID: 24984537
[TBL] [Abstract][Full Text] [Related]
22. Cervical small cell carcinoma frequently presented in multiple high risk HPV infection and often associated with other type of epithelial tumors.
Li P; Ma J; Zhang X; Guo Y; Liu Y; Li X; Zhao D; Wang Z
Diagn Pathol; 2018 May; 13(1):31. PubMed ID: 29788963
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of neuroendocrine small cell carcinoma of the cervix metastatic to regional lymph nodes.
Kim YB; Barbuto D; Lagasse LD; Karlan BY
Gynecol Oncol; 1996 Sep; 62(3):411-4. PubMed ID: 8812543
[TBL] [Abstract][Full Text] [Related]
24. [Neuroendocrine carcinoma of the cervix: a case report and review of the literature].
Baggar S; Ouahbi H; Azegrar M; El M'rabet FZ; Arifi S; Mellas N
Pan Afr Med J; 2017; 27():82. PubMed ID: 28819503
[TBL] [Abstract][Full Text] [Related]
25. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
[No Abstract] [Full Text] [Related]
26. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
Yuan L; Jiang H; Lu Y; Guo SW; Liu X
Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
[TBL] [Abstract][Full Text] [Related]
28. Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine Cervix.
Masuda M; Iida K; Iwabuchi S; Tanaka M; Kubota S; Uematsu H; Onuma K; Kukita Y; Kato K; Kamiura S; Nakajima A; Coppo R; Kanda M; Yoshino K; Ueda Y; Morii E; Kimura T; Kondo J; Okada-Hatakeyama M; Hashimoto S; Inoue M
Am J Pathol; 2024 Mar; 194(3):415-429. PubMed ID: 38103888
[TBL] [Abstract][Full Text] [Related]
29. Low-grade Neuroendocrine Tumor of the Cervix: Report of 3 Cases of a Rare Neoplasm With Review of the Literature.
Sah S; Borkar PV; Wight C; Kelly P; Park KJ; McCluggage WG
Int J Gynecol Pathol; 2022 Sep; 41(5):437-446. PubMed ID: 35075048
[TBL] [Abstract][Full Text] [Related]
30. Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009.
Zhang Y; Ding J; Hua K
J Int Med Res; 2022 Jan; 50(1):3000605211067397. PubMed ID: 34986672
[TBL] [Abstract][Full Text] [Related]
31. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.
Viswanathan AN; Deavers MT; Jhingran A; Ramirez PT; Levenback C; Eifel PJ
Gynecol Oncol; 2004 Apr; 93(1):27-33. PubMed ID: 15047210
[TBL] [Abstract][Full Text] [Related]
32. HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.
Kraft S; Faquin WC; Krane JF
Am J Surg Pathol; 2012 Mar; 36(3):321-30. PubMed ID: 22301491
[TBL] [Abstract][Full Text] [Related]
33. Ubiquitin C-terminal hydrolase L1 promotes lymph node metastasis in small cell neuroendocrine carcinomas of the cervix.
Zhang Y; Ding J; Zhang X; Hua K
J Int Med Res; 2022 Apr; 50(4):3000605221087620. PubMed ID: 35400238
[TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine small cell carcinoma of the uterine cervix.
Reig Castillejo A; Membrive Conejo I; Foro Arnalot P; Rodríguez de Dios N; Algara López M
Clin Transl Oncol; 2010 Jul; 12(7):512-3. PubMed ID: 20615830
[TBL] [Abstract][Full Text] [Related]
35. Dedifferentiation of neuroendocrine carcinoma of the uterine cervix in hypoxia.
Kubota S; Tanaka M; Endo H; Ito Y; Onuma K; Ueda Y; Kamiura S; Yoshino K; Kimura T; Kondo J; Inoue M
Biochem Biophys Res Commun; 2020 Apr; 524(2):398-404. PubMed ID: 32007268
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
[TBL] [Abstract][Full Text] [Related]
37. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
[TBL] [Abstract][Full Text] [Related]
38. HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity.
Jo VY; Krane JF; Pantanowitz L; Monaco SE
Cancer Cytopathol; 2019 Feb; 127(1):26-34. PubMed ID: 30475447
[TBL] [Abstract][Full Text] [Related]
39. Small cell neuroendocrine cervical carcinoma with 1-year follow-up: case report and review.
Bifulco G; Mandato VD; Giampaolino P; Piccoli R; Insabato L; De Rosa N; Nappi C
Anticancer Res; 2009 Feb; 29(2):477-84. PubMed ID: 19331190
[TBL] [Abstract][Full Text] [Related]
40. Treatment policy of neuroendocrine small cell cancer of the cervix.
Trinh XB; Bogers JJ; Van Marck EA; Tjalma WA
Eur J Gynaecol Oncol; 2004; 25(1):40-4. PubMed ID: 15053060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
